Moderna starts testing coronavirus vaccine's effectiveness among teens

Massachusetts biotech company Moderna, which is at the cutting edge of a coronavirus vaccine, announced Thursday it has begun testing its vaccine's efficacy among adolescents ages 12 to 17.